Table 5.
MINORS—risk of bias assessment of nonrandomized studies.
Variable | Padolino11 | Katthagen12 | Schliemann13 | Mitchell15 | Byun16 | Guzzini17 | Ziran18 |
---|---|---|---|---|---|---|---|
1.A clearly stated aim | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
2. Inclusion of consecutive patients | 0 | 0 | 2 | 0 | 0 | 2 | 2 |
3. Prospective collection of data | 0 | 2 | 2 | 0 | 0 | 2 | 0 |
4. Endpoints appropriate for aim of study | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
5. Unbiased assessment of the study endpoint | 0 | 0 | 2 | 0 | 0 | 0 | 2 |
6. Follow-up period appropriate for aim of the study | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
7. Loss of follow-up less than 5% | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
8. Prospective calculation of the study size | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
9. An adequate control group | 2 | 2 | 2 | 0 | 0 | 2 | 2 |
10. Contemporary groups | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
11. Baseline equivalence of groups | 2 | 0 | 2 | 0 | 0 | 0 | 2 |
12. Adequate statistical analyses | 0 | 0 | 2 | 0 | 0 | 0 | 2 |
TOTAL (maximum score: 24) | 14 | 10 | 18 | 6 | 6 | 12 | 16 |
Quality of evidence | Fair | Fair | Good | Very Low | Very Low | Fair | Fair |
Score: 0 (not adequate), 2 (reported and adequate).